InvestorsHub Logo
Followers 134
Posts 3758
Boards Moderated 0
Alias Born 01/28/2006

Re: Lemoncat post# 336263

Friday, 12/11/2020 6:38:51 PM

Friday, December 11, 2020 6:38:51 PM

Post# of 403752
If Brilacidin for Covid 19 works as well in Covid patients as it it did in the test tube its value becomes almost incalculable. Virtually every country in the world is struggling with not only a pandemic health crisis but an economic catastrophe costing trillions of dollars.

Remember the EU paid over a billion dollars for 500,000 Remdesivir treatment courses {does Remdesivir even work?}

https://www.reuters.com/article/us-health-coronavirus-eu-remdesivir/eu-makes-1-billion-euro-bet-on-gileads-covid-drug-before-trial-results-idUSKBN26Y25K

If Brilacidin really works you can multiple that figure by several double digit multiples just for Europe;then multiply that result by several additional multiples for each geographic area on earth. Then add some for short covering and a bidding war.

At that point Brilacidin's valuation will easily exceed the vaccine valuations.

If Brilacidin works the cost would be justified. What is it worth to the world wide economy for people to be able to go to work without fearing for their health or their familliy's well being?

Imagine traveling without fear, eating out, having a drink with friends at the bar,attending a religious service,weddings, funerals, class reunions, visiting mom at the nursing home. Covid has cost us a lot and we will gladly pay to restore our lives.

In my opinion we are going to know if Brilacidin is part of the answer in a few weeks.

GLTA,Farrell